Patents by Inventor Davinder Tuli

Davinder Tuli has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SUBSTITUTED FUSED PYRIMIDINONE COMPOUNDS
    Publication number: 20190127381
    Abstract: Provided herein are novel fused pyrimidinone derivatives of Formula I and synthetic intermediates that are useful in preparing the compounds of formula (I). Further provided herein is a method for preparation of a compound of formula (I) or intermediates, a pharmaceutical composition comprising a compound of formula (I), and use of a compound of formula (I).
    Type: Application
    Filed: April 25, 2017
    Publication date: May 2, 2019
    Applicant: TORRENT PHARMACEUTICALS LIMITED
    Inventors: Chaitanya DUTT, Deepa JOSHI, Milind RODE, Sanjay SRIVASTAVA, Davinder TULI, Ramesh Chandra GUPTA, Deepak RAI, Prashant JAMADARKHANA, Shailesh DESHPANDE, Vivek MISHRA, Jaya ABRAHAM
  • Novel Substituted Imidazopyrimidines as Gpbar1 Receptor Modulators
    Publication number: 20150126530
    Abstract: The present invention relates to novel substituted imidazo[1,2-a]pyrimidine compounds of formula (I), their pharmaceutically acceptable salts, and their isomers, stereoisomers, conformers, tautomers, polymorphs, hydrates and solvates. The present invention also encompasses pharmaceutically acceptable compositions of said compounds and process for preparing novel compounds. The invention further” relates to the use of the above-mentioned compounds for the preparation of medicament for use as pharmaceuticals. (Formula I).
    Type: Application
    Filed: October 15, 2012
    Publication date: May 7, 2015
    Applicant: Torrent Pharmaceuticals Limited
    Inventors: Chaitanya Dutt, Vijay Chauthaiwale, Ramesh Chandra Gupta, Sameer Ghalsasi, Davinder Tuli, Shailesh Deshpande, Anita Chaudhari, Shitalkumar Zambad
  • Pyrazole-based thyroid receptor compounds
    Patent number: 8378118
    Abstract: The present invention discloses a novel thyroid like compounds of formula (I), wherein R1 R2, R3, R4 and Z are as defined in the specification, method for its preparation, composition containing such compounds and use of such compounds and composition as medicament. Further, compounds of formula (I) has significantly low binding affinity to thyroid receptors and thus considerably devoid of thyrotoxic effects. The invention also relates to the use of the compound of formula (I) for the preparation of a medicament for treating various disease conditions such as obesity, dyslipidemia, metabolic syndrome and co-morbidities associated with metabolic syndrome.
    Type: Grant
    Filed: January 10, 2012
    Date of Patent: February 19, 2013
    Assignee: Torrent Pharmaceuticals Ltd.
    Inventors: Laxmikant Chhipa, Shitalkumar Pukharaj Zambad, Ramesh Gupta, Davinder Tuli, Ashok Kasundra, Siralee Munshi, M. Amir Siddiqui, Subrat Kumar Bhattamisra, C. Dutt, Vijay Chauthaiwale
  • NOVEL COMPOUNDS
    Publication number: 20120202816
    Abstract: The present invention discloses a novel thyroid like compounds of formula (I), wherein R1 R2, R3, R4 and Z are as defined in the specification, method for its preparation, composition containing such compounds and use of such compounds and composition as medicament. Further, compounds of formula (I) has significantly low binding affinity to thyroid receptors and thus considerably devoid of thyrotoxic effects. The invention also relates to the use of the compound of formula (I) for the preparation of a medicament for treating various disease conditions such as obesity, dyslipidemia, metabolic syndrome and co-morbidities associated with metabolic syndrome.
    Type: Application
    Filed: January 10, 2012
    Publication date: August 9, 2012
    Applicant: Torrent Pharmaceuticals, Ltd.
    Inventors: Laxmikant Chhipa, Shitalkumar Pukharaj Zambad, Ramesh Gupta, Davinder Tuli, Ashok Kasundra, Siralee Munshi, M. Amir Siddiqui, Subrat Kumar Bhattamisra, C. Dutt, Vijay Chauthaiwale
  • Thyroid like compounds
    Patent number: 8143424
    Abstract: A novel thyroid like compounds of formula (I), wherein R1, R2, R3, R4 and Z are as defined in the specification, method for its preparation, composition and use thereof. Further, compounds of formula (I) has significantly low binding affinity to thyroid receptors and thus considerably devoid of thyrotoxic effects. The invention also relates to the use of the compound of formula (I) for the preparation of a medicament for treating various disease conditions including obesity, dyslipidemia, metabolic syndrome and co-morbidities associated with metabolic syndrome.
    Type: Grant
    Filed: June 2, 2008
    Date of Patent: March 27, 2012
    Assignee: Torrent Pharmaceuticals Ltd.
    Inventors: Laxmikant Chhipa, Shitalkumar Pukharaj Zambad, Ramesh Gupta, Davinder Tuli, Ashok Kasundra, Siralee Munshi, M. Amir Siddiqui, Subrat Kumar Bhattamisra, Chaitanya Dutt, Vijay Chauthaiwale
  • Thiazolopyridine derivatives, pharmaceut ical conditions containing them and methods of treating glucokinase mediated conditions
    Patent number: 7781451
    Abstract: The present invention provides compounds of the formula which are activators of glucokinase activity and, thus, may be employed as therapeutic agents for the treatment of glucokinase mediated conditions. Accordingly, the compounds of formula (I) may be employed for the prevention and the treatment of impaired glucose tolerance, Type 2 diabetes and obesity.
    Type: Grant
    Filed: April 1, 2005
    Date of Patent: August 24, 2010
    Assignee: Novartis AG
    Inventors: Gregory R Bebernitz, Ramesh C Gupta, Vikrant V Jagtap, Appaji B Mandhare, Davinder Tuli
  • Sulfonamide-thiazolpyridine derivatives as glucokinase activators useful the treatment of Type 2 diabetes
    Patent number: 7750020
    Abstract: The present invention provides compounds of the formula (I), which are activators of glucokinase activity and, thus, may be employed as therapeutic agents for the treatment of glucokinase mediated conditions. Accordingly, the compounds of formula (I) may be employed for the prevention and the treatment of impaired glucose tolerance, Type 2 diabetes and obesity.
    Type: Grant
    Filed: April 1, 2005
    Date of Patent: July 6, 2010
    Assignee: Novartis AG
    Inventors: Gregory Raymond Bebernitz, Ramesh Chandra Gupta, Vikrant Vijaykumar Jagtap, Appaji Baburao Mandhare, Davinder Tuli
  • Novel Compounds
    Publication number: 20100168110
    Abstract: The present invention discloses a novel thyroid like compounds of formula (I), wherein R1 R2, R3, R4 and Z are as defined in the specification, method for its preparation, composition containing such compounds and use of such compounds and composition as medicament. Further, compounds of formula (I) has significantly low binding affinity to thyroid receptors and thus considerably devoid of thyrotoxic effects. The invention also relates to the use of the compound of formula (I) for the preparation of a medicament for treating various disease conditions such as obesity, dyslipidemia, metabolic syndrome and co-morbidities associated with metabolic syndrome.
    Type: Application
    Filed: June 2, 2008
    Publication date: July 1, 2010
    Applicant: TORRENT PHARMACEUTICALS LTD.
    Inventors: Laxmikant Chhipa, Shitalkumar Zambad, Ramesh Gupta, Davinder Tuli, Ashok Kasundra, Siralee Munshi, M. Amir Siddiqui, Subrat Kumar Bhattamisra, C. Dutt, Vijay Chauthaiwale
  • Thiazolinones and Oxazolinones and their Use as Ptp1b Inhibitors
    Publication number: 20090088432
    Abstract: The present invention encompasses; the novel substituted heterocyclic compounds represented by formula (I) or their pharmaceutically acceptable salts, wherein the substituents in formula (I) have the meanings as defined in the specification. The invention also encompasses process for preparing such compound, pharmaceutical compositions and methods of treating or preventing PTP-1B mediated diseases.
    Type: Application
    Filed: September 15, 2006
    Publication date: April 2, 2009
    Inventors: Rakesh Kumar Banerjee, Ramesh Chandra Gupta, Davinder Tuli, Milind Rode, Bharat Suthar, Dhananjay Umrani, Padmaja Pathak, Tejal Choksi, Anita Chaudhary
  • Sulfonamide-Thiazolpyridine Derivatives As Glucokinase Activators Useful The Treatment Of Type 2 Diabetes
    Publication number: 20080103167
    Abstract: The present invention provides compounds of the formula (I), which are activators of glucokinase activity and, thus, may be employed as therapeutic agents for the treatment of glucokinase mediated conditions. Accordingly, the compounds of formula (I) may be employed for the prevention and the treatment of impaired glucose tolerance, Type 2 diabetes and obesity.
    Type: Application
    Filed: April 1, 2005
    Publication date: May 1, 2008
    Inventors: Gregory Raymond Bebernitz, Ramesh Chandra Gupta, Vikrant Vijaykumar Jagtap, Appaji Baburao Mandhare, Davinder Tuli
  • Thiazolopyridine Derivatives, Pharmaceut Ical Conditions Containing Them And Methods Of Treating Glucokinase Mediated Conditions
    Publication number: 20070265297
    Abstract: The present invention provides compounds of the formula which are activators of glucokinase activity and, thus, may be employed as therapeutic agents for the treatment of glucokinase mediated conditions. Accordingly, the compounds of formula (I) may be employed for the prevention and the treatment of impaired glucose tolerance, Type 2 diabetes and obesity.
    Type: Application
    Filed: April 1, 2005
    Publication date: November 15, 2007
    Applicant: NOVARTIS AG
    Inventors: Gregory Bebernitz, Ramesh Gupta, Vikrant Jagtap, Appaji Mandhare, Davinder Tuli